Dermal Fillers
This category hub supports clinic teams sourcing injectable facial fillers for aesthetic practice. It covers common filler families, typical use areas, and label-first considerations. Content is written for licensed healthcare professionals, not consumer self-selection. Inventory planning can also benefit from clear nomenclature and packaging details. The site supports US distribution for authorized clinical accounts. Use this page to compare options, then open linked pages for specifics.
Most listings here are hyaluronic acid fillers, plus biostimulatory (collagen-stimulating) injectables. Product detail pages may list syringe size, lidocaine inclusion, and intended tissue plane. Related reading is also available through the Dermal Fillers editorial hub.
What You’ll Find in This Category
This category groups injectable facial fillers used for facial volume restoration and contour support. Many items are HA gels intended for wrinkles, folds, and volume deficits. Some listings are non-HA options, including CaHA and PLLA products. Individual pages may describe viscosity, crosslinking approach, and anesthetic presence. Some clinics also browse adjunct categories like Dermal Filler Removal for reversal and correction workflows.
Product pages can help teams align documentation with internal protocols. Examples include HA portfolio references like Restylane 1 mL. Biostimulatory options may appear as specific items, such as Radiesse 3 mL and Sculptra 2 Vials. Always confirm indication and handling in the current IFU.
- HA gels for lines, folds, and soft tissue augmentation.
- Options labeled with lidocaine for procedural comfort considerations.
- Biostimulatory injectables for structured support and gradual correction planning.
- Skin quality adjuncts, sometimes grouped as skin boosters or hydrators.
- Products for lip, cheek, chin, and jawline contour workflows.
- Under eye applications referenced as tear trough support in some practices.
- Accessories listed separately, including needles and cannulas when available.
Stock is supplied as brand-name units sourced through screened distribution partners.
How to Choose injectable facial fillers
Selection starts with the on-label indication and the planned tissue plane. Teams often compare rheology (flow and elasticity) to match technique and region. Consider reversibility needs when choosing between HA and non-HA options. Align syringe size and lidocaine labeling with typical appointment workflows. For brand browsing, the Dermalax Brand Hub can help standardize assortments.
Key comparison checkpoints
- Filler family: HA versus CaHA or PLLA formulations.
- Crosslinking style and gel firmness, when stated on labeling.
- Intended depth: superficial dermis versus deep subcutaneous placement.
- Primary goal: wrinkle softening versus structural contour support.
- Target region terms: nasolabial folds, marionette lines, lips, cheeks.
- Use of needle versus cannula, based on clinic technique standards.
- Lidocaine inclusion and any sensitivity documentation requirements.
- Packaging format: syringes, vials, and number of units per pack.
- Training needs for high-risk zones, including periocular regions.
- Availability of reversal or correction pathways in clinic protocols.
Common browsing pathways
Some teams start by region, then filter by gel behavior and depth. Others standardize by manufacturer lines to reduce intra-staff variability. Combination planning may include neuromodulators alongside filler protocols. A neutral overview is available at Botox And Fillers Combined.
Safety and Use Notes
Injectable facial fillers are prescription devices or drugs, depending on jurisdiction. Review contraindications, warnings, and adverse event sections on each label. High-level risks include infection, nodules, and vascular occlusion (blocked blood vessel). Extra caution is needed in high-risk anatomy and compromised tissue. Use of aspiration, cannula choice, and plane selection are clinical decisions. Those decisions should follow training, policies, and local regulations.
For regulatory context, see FDA guidance in this FDA overview of dermal fillers and risks. Documentation should support lot traceability and post-procedure monitoring. Clinics may also align policies with specialty society statements when available. Related reading can help staff maintain consistent terminology across teams. See Botox Vs Dysport Vs Xeomin for workflow comparisons in adjacent injectables.
- Confirm product identity, lot number, and expiry before clinic use.
- Follow IFU storage limits and light protection requirements.
- Do not substitute needles, diluents, or components across systems.
- Escalate any suspected adverse events through clinic reporting processes.
- Maintain protocol access for emergency response and escalation pathways.
Why it matters: Standardized checks reduce preventable handling and identification errors.
All items are supplied as authentic, manufacturer-labeled products for professional channels.
Clinic Ordering and Compliance Notes
Ordering is limited to licensed clinics and qualified healthcare professionals. Account verification typically includes license review and practice identification details. Product availability and allowable destinations can vary by item and jurisdiction. Keep purchaser-of-record and ship-to details consistent across orders. Use injectable facial fillers listings to compare pack formats before restocking.
Receiving processes should include inspection for tamper evidence and shipping damage. Store inventory per carton instructions, including temperature range and light exposure. Track lot numbers for documentation and recall readiness. Clinics should also separate training stock from patient-use stock. For adjacent treatment planning context, see Skin Boosters Injections.
- Upload required credentials in the account area when prompted.
- Document chain-of-custody steps in internal receiving logs.
- Quarantine items with compromised packaging until disposition is documented.
- Record lot numbers in the patient chart per clinic policy.
- Store returned or held stock in clearly labeled, segregated locations.
Quick tip: Keep lot numbers and expiry dates in one inventory register.
Access is restricted to verified healthcare accounts supplied through vetted distributor networks.
This content is for informational purposes only and is not a substitute for professional medical advice.
FILTERS
Price
Product categories
Brands
Aliaxin® EV Essential Volume
Aliaxin® FL Lips Filler
Aliaxin® GP Global Performance
Aliaxin® LV Lips Volume
Aliaxin® SV Superior Volume
Bellast® Soft-L
Belotero® Intense w/ Lidocaine
Belotero® Lips Contour w/ Lidocaine
Belotero® Lips Shape w/ Lidocaine
Frequently Asked Questions
What types of fillers are included in this category?
This category can include hyaluronic acid (HA) gels, biostimulatory injectables, and related skin quality products. Listings may cover wrinkle fillers, volumizers for cheeks or chin, and products positioned for lips or under eye areas. Each product page should be reviewed for labeled indications, syringe or vial format, and lidocaine inclusion. Some sites also group complementary items, such as filler removal products or accessories, in nearby categories.
How do hyaluronic acid fillers differ from biostimulatory fillers?
Hyaluronic acid fillers are gels designed to provide immediate space-occupying volume and contour support. Many HA products can be adjusted or reversed using hyaluronidase, when clinically appropriate and available. Biostimulatory (collagen-stimulating) options use different materials, such as CaHA or PLLA, and are typically managed using label-specific protocols. Selection depends on labeled use, anatomy, desired texture, and the clinic’s training and emergency preparedness.
What safety topics should clinic teams review before use?
Teams should review the current IFU for contraindications, warnings, and handling requirements. Core risks include infection, inflammatory reactions, nodules, and intravascular injection events. Clinics often standardize pre-use verification steps, including product identity, lot number, and expiry checks. Emergency response pathways should be defined, including escalation criteria and documentation. For HA products, clinics may also maintain a protocol for managing suspected vascular compromise, aligned with training and local guidance.
What documentation is typically required for wholesale access?
Wholesale access is commonly limited to licensed clinics and healthcare professionals. Sites may request professional license details, practice address verification, and a designated authorized purchaser. Some products may require additional acknowledgments tied to regulated device or drug distribution rules. Clinics typically maintain internal records for lot traceability and purchasing audits. Requirements can differ by jurisdiction and product type, so confirmation during account setup and checkout review is standard.
What does “with lidocaine” mean on a filler label?
“With lidocaine” indicates the product includes lidocaine as an anesthetic component within the syringe or vial. Labeling can specify the amount or concentration, and it may vary across product lines. Clinics should screen for relevant allergies and follow the product’s contraindications and warnings. Lidocaine inclusion can affect consent language, documentation, and adverse event evaluation. Always rely on the product’s approved labeling and clinic policy for interpretation.
How should fillers be stored and logged after receipt?
Storage should follow the carton label and IFU, including temperature range, light protection, and handling precautions. On receipt, clinics often inspect packaging integrity and confirm lot and expiry information. Inventory logs commonly record product name, lot number, expiry date, and receiving date. Items with damaged packaging are typically quarantined until disposition is documented. Storage location should support segregation of expired, held, and active stock to reduce selection errors.